Excluded Methods | Agricultural Marketing Service

Scope

Multiple

Status

Under NOSB Review

NOSB Review Documents

1995 – Current ongoing NOSB review in the NOSB Materials/GMO Subcommittee of terminology and techniques that may be considered excluded methods (Crops, Handling, and Livestock scopes)
1995 NOSB review for addition to §205.105 and §205.603 for use as a livestock medical treatment (biologics-vaccines)
November 1995 NOSB Recommendation (pdf) (page 3-4) (biologics-vaccines)
March 2007 NOSB Recommendation (pdf) (cloning)
2009 NOSB review to change §205.105(e) annotation (biologics-vaccines)
November 2009 NOSB Recommendation (pdf) (biologics-vaccines)
September 2010 NOP Memorandum (pdf) to the NOSB requesting a review of vaccines in accordance with §205.600(a) (biologics-vaccines)
2011 Technical Report (pdf) (GMO vaccines) (biologics-vaccines)
May 2012 NOSB Livestock Subcommittee Proposal (pdf) (biologics-vaccines)
May 2012 NOSB Materials Subcommittee Proposal (pdf) (letter to the Secretary)
May 2012 NOSB Recommendation (pdf) (letter to the Secretary)
October 2012 NOSB Materials Subcommittee Discussion Document (pdf) (genetic transparency of seed)
February 2013 NOSB Livestock Subcommittee Interim Report: Identifying Vaccines Made with Excluded Methods (pdf) (biologics-vaccines)
April 2013 NOSB Materials Subcommittee Discussion Document (pdf) (Genetic transparency of seed)
April 2013 NOSB Materials Subcommittee Discussion Document (pdf)
April 2014 NOSB Materials Subcommittee Report (pdf) (genetic transparency of seed)
April 2014 NOSB Recommendation (pdf) (page 9): none, delivered report (genetic transparency of seed)
October 2014 NOSB Materials Subcommittee Discussion Document (pdf)
October 2014 NOSB Livestock Subcommittee Proposal (pdf) (biologics-vaccines)
October 2014 NOSB Recommendation (pdf) (biologics-vaccines)
April 2015 NOSB Materials Subcommittee Discussion Document (pdf) (prevention strategy)
April 2015 NOSB Materials Subcommittee Discussion Document (pdf)
April 2015 NOSB Meeting - Guest Speaker Presentation (pdf) (genetic transparency of seed)
October 2015 NOSB Materials Subcommittee Proposal (pdf) (prevention strategy)
October 2015 NOSB Recommendation (pdf) (prevention strategy)
April 2016 NOSB Materials Subcommittee Discussion Document (pdf) (genetic transparency of seed)
April 2016 NOSB Materials Subcommittee Discussion Document (pdf)
April 2016 NOSB Materials Subcommittee Proposal (pdf)
April 2016 NOSB Recommendation (pdf): none, sent back to Subcommittee
November 2016 NOSB Materials Subcommittee Discussion Document (pdf)
November 2016 NOSB Materials Subcommittee Proposal (pdf)
November 2016 NOSB Materials Subcommittee Proposal (pdf) (letter to the Secretary)
November 2016 NOSB Recommendation (pdf)
November 2016 NOSB Recommendation (pdf) (letter to the Secretary)
October 2017 NOSB Materials Subcommittee Discussion Document (pdf) (genetic transparency of seed)
October 2017 NOSB Materials Subcommittee Proposal (pdf)
October 2017 NOSB Recommendation (pdf)
April 2018 NOSB Materials Subcommittee Discussion Document (pdf) (genetic transparency of seed)
October 2018 NOSB Materials Subcommittee Proposal (pdf) (genetic transparency of seed)
October 2018 NOSB Materials Subcommittee Proposal (pdf)
October 2018 NOSB Recommendation (pdf)
2019 NOSB review to change §205.105(e) annotation (biologics-vaccines)
April 2019 NOSB Livestock Subcommittee Discussion Document (pdf) (biologics-vaccines)
April 2019 NOSB Materials Subcommittee Discussion Document (pdf) (genetic transparency of seed)
April 2019 NOSB Materials Subcommittee Discussion Document (pdf) (embryo transfer) (induced mutagenesis)
April 2019 NOSB Materials Subcommittee Proposal (pdf)
April 2019 NOSB Recommendation (pdf)
October 2019 NOSB Livestock Subcommittee Proposal (pdf) (biologics-vaccines)
October 2019 NOSB Materials Subcommittee Proposal (pdf) (genetic transparency of seed)
October 2019 NOSB Materials Subcommittee Proposal (pdf) (embryo transfer) (induced mutagenesis)
October 2019 NOSB Recommendation (pdf) (biologics-vaccines)
October 2019 NOSB Recommendation (pdf) (embryo transfer) (induced mutagenesis)
April 2021 NOSB Materials Subcommittee Discussion Document (pdf)
October 2021 NOSB Materials Subcommittee Discussion Document (pdf) (cell fusion) (protoplast fusion) (guidance for table of definitions, criteria, excluded, and allowed methods)
April 2022 NOSB Materials Subcommittee Proposal (pdf) (cell fusion) (protoplast fusion)
April 2022 NOSB Recommendation (pdf) (cell fusion) (protoplast fusion)
April 2023 NOSB Materials Subcommittee Discussion Document (pdf) (plant breeding techniques)
2023 Technical Report (pdf) (induced mutagenesis)
October 2024 NOSB Subcommittee Discussion Document (pdf) (induced mutagenesis)
NOSB Recommendation: TBD (induced mutagenesis)

Rulemaking

Added to Terms defined, §205.2, and Allowed and prohibited substances, methods, and ingredients in organic production and handling, §205.105, effective April 21, 2001 (65 FR 80548, 66 FR 15619)
Not recommended for rulemaking by NOSB: NOP Policy Memorandum PM 11-13: Genetically modified organisms (pdf) (2011).
Not recommended for rulemaking by NOSB: NOP Policy Memorandum PM 13-1: Cell Fusion Techniques used in Seed Production (2013).

Related Terms

Accelerated plant breeding techniques; Agro-infiltration; Biologics-vaccines; Cell fusion; Cisgenesis; Clones; Cloning; Clustered regularly interspaced short palindromic repeats (CRISPER-Cas system, CRISPER-associated protein); Doubled haploid technology (DHT); Eco-TILLING; Embryo rescue; Embryo transfer; Fast flowering; FasTrack; Gene editing; Gene silencing; Gene targeting; Genetic engineering (GE); Genetically engineered (GE); Genetically modified organisms (GMO); Genome elimination; Genome engineering; Induced mutagenesis; Intragenesis; Macroencapsulation; Marker assisted selection; Meganucleases zinc finger nuclease (ZFN); Microencapsulation; Modern biotechnology; Oligonucleotides-directed mutagenesis (ODM); Plastid transformation; Protoplast fusion; Recombinant DNA technology; Reverse breeding; Sequence-specific nucleases (SSNs); Synthetic biology; Synthetic gene technologies; Targeted genetic modification (TagMo); TILLING; Transcription activator-like effector nucleases (TALENs); Transduction; Transposons.

Date Updated

09/09/2024